147 related articles for article (PubMed ID: 29619295)
1. Multidrug Resistance in Cancer Circumvented Using a Cytosolic Drug Reservoir.
Fan L; Zhang S; Zhang C; Yin C; Chu Z; Song C; Lin G; Li Q
Adv Sci (Weinh); 2018 Feb; 5(2):1700289. PubMed ID: 29619295
[TBL] [Abstract][Full Text] [Related]
2. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
3. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
4. Overcoming multidrug resistance in 2D and 3D culture models by controlled drug chitosan-graft poly(caprolactone)-based nanoparticles.
Shi WB; Le VM; Gu CH; Zheng YH; Lang MD; Lu YH; Liu JW
J Pharm Sci; 2014 Apr; 103(4):1064-74. PubMed ID: 24523221
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology as a therapeutic tool to combat microbial resistance.
Pelgrift RY; Friedman AJ
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
[TBL] [Abstract][Full Text] [Related]
6. A pH/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer.
Chang N; Zhao Y; Ge N; Qian L
Drug Deliv; 2020 Dec; 27(1):1073-1086. PubMed ID: 32706272
[TBL] [Abstract][Full Text] [Related]
7. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
[TBL] [Abstract][Full Text] [Related]
8. Transferrin-inspired vehicles based on pH-responsive coordination bond to combat multidrug-resistant breast cancer.
He YJ; Xing L; Cui PF; Zhang JL; Zhu Y; Qiao JB; Lyu JY; Zhang M; Luo CQ; Zhou YX; Lu N; Jiang HL
Biomaterials; 2017 Jan; 113():266-278. PubMed ID: 27842254
[TBL] [Abstract][Full Text] [Related]
9. Activity of the multidrug transporter results in alkalinization of the cytosol: measurement of cytosolic pH by microinjection of a pH-sensitive dye.
Thiebaut F; Currier SJ; Whitaker J; Haugland RP; Gottesman MM; Pastan I; Willingham MC
J Histochem Cytochem; 1990 May; 38(5):685-90. PubMed ID: 1692055
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
Tam YT; To KK; Chow AH
Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional nanoparticles as nanocarrier for vincristine sulfate delivery to overcome tumor multidrug resistance.
Wang Y; Dou L; He H; Zhang Y; Shen Q
Mol Pharm; 2014 Mar; 11(3):885-94. PubMed ID: 24483832
[TBL] [Abstract][Full Text] [Related]
12. A new combination strategy to enhance apoptosis in cancer cells by using nanoparticles as biocompatible drug delivery carriers.
Kucuksayan E; Bozkurt F; Yilmaz MT; Sircan-Kucuksayan A; Hanikoglu A; Ozben T
Sci Rep; 2021 Jun; 11(1):13027. PubMed ID: 34158544
[TBL] [Abstract][Full Text] [Related]
13. Design of light/ROS cascade-responsive tumor-recognizing nanotheranostics for spatiotemporally controlled drug release in locoregional photo-chemotherapy.
Zuo W; Chen D; Fan Z; Chen L; Zhu Z; Zhu Q; Zhu X
Acta Biomater; 2020 Jul; 111():327-340. PubMed ID: 32434075
[TBL] [Abstract][Full Text] [Related]
14. Targeted cytosolic delivery of cell-impermeable compounds by nanoparticle-mediated, light-triggered endosome disruption.
Febvay S; Marini DM; Belcher AM; Clapham DE
Nano Lett; 2010 Jun; 10(6):2211-9. PubMed ID: 20446663
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles of cisplatin augment drug accumulations and inhibit multidrug resistance transporters in human glioblastoma cells.
Maliyakkal N; Appadath Beeran A; Udupa N
Saudi Pharm J; 2021 Aug; 29(8):857-873. PubMed ID: 34408546
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of negative-charged nanoparticles assisted by ultrasound on the reversal multidrug resistance phenotype in breast cancer cells.
Wang D; Luo W; Wen G; Yang L; Hong S; Zhang S; Diao J; Wang J; Wei H; Li Y; Wang Y
Ultrason Sonochem; 2017 Jan; 34():448-457. PubMed ID: 27773267
[TBL] [Abstract][Full Text] [Related]
17. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro.
Kievit FM; Wang FY; Fang C; Mok H; Wang K; Silber JR; Ellenbogen RG; Zhang M
J Control Release; 2011 May; 152(1):76-83. PubMed ID: 21277920
[TBL] [Abstract][Full Text] [Related]
19. Light induced cytosolic drug delivery from liposomes with gold nanoparticles.
Lajunen T; Viitala L; Kontturi LS; Laaksonen T; Liang H; Vuorimaa-Laukkanen E; Viitala T; Le Guével X; Yliperttula M; Murtomäki L; Urtti A
J Control Release; 2015 Apr; 203():85-98. PubMed ID: 25701610
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic/Pharmacodynamics Modeling of Drug-Loaded PLGA Nanoparticles Targeting Heterogeneously Vascularized Tumor Tissue.
Miller HA; Frieboes HB
Pharm Res; 2019 Nov; 36(12):185. PubMed ID: 31773287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
